Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumor cancers; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has an early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Editas Medicine Inc..
Editas Medicine Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Editas Medicine Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Editas Medicine Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Editas Medicine Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Editas Medicine Inc. and all latest updates of the company are provided.
The 2025 version of Editas Medicine Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Editas Medicine Inc.- Key Facts
2.2 Editas Medicine Inc.- Geographic Locations
2.3 Editas Medicine Inc.- Subsidiaries and Affiliates
2.4 Editas Medicine Inc.- Business Divisions
2.5 Editas Medicine Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Editas Medicine Inc. Strategic Analysis Review
3.1 Editas Medicine Inc.- Key Strategies
3.2 Editas Medicine Inc.- Company Outlook Statement
3.3 Editas Medicine Inc.- SWOT Analysis
3.3.1 Editas Medicine Inc.- Key Strengths
3.3.2 Editas Medicine Inc.- Key Weaknesses
3.3.3 Editas Medicine Inc.- Potential Opportunities
3.3.4 Editas Medicine Inc.- Potential Threats
3.4 Editas Medicine Inc.- Key Competitors
4. Business Description of the Company
4.1 Editas Medicine Inc.- Business Overview
4.2 Editas Medicine Inc.- Operations by Segment
5 Products and Services Details
5.1 Editas Medicine Inc.- Key Products
5.2 Editas Medicine Inc.- Key Service Areas
5.3 Editas Medicine Inc.- Key Brands
6 Company Developments
6.1 Editas Medicine Inc.- Company History
6.2 Editas Medicine Inc.- Latest Developments
7 Financial Analysis
7.1 Editas Medicine Inc.- Income Statements
7.2 Editas Medicine Inc.- Balance Sheet
7.3 Editas Medicine Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Editas Medicine Inc.- Direct Competitors
8.2 Editas Medicine Inc.- Competitor Financial Ratios comparison
8.3 Editas Medicine Inc.- Competitor Stock Charts Comparison
8.4 Editas Medicine Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
